FDA Drug Recalls
1,739 recalls · Class I, newest first
Class I · High risk Terminated Mar 19, 2021
Reason Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a…
Class I · High risk Terminated Mar 17, 2021
Reason Labeling: Label-mixup
Class I · High risk Terminated Mar 10, 2021
Reason Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia…
Class I · High risk Terminated Mar 10, 2021
Reason Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia…
Class I · High risk Terminated Mar 10, 2021
Reason Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.
Class I · High risk Terminated Mar 2, 2021
Reason Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled…
Class I · High risk Terminated Feb 18, 2021
Reason Crystallization: customer complaints for crystallization in finished product.
Class I · High risk Terminated Feb 18, 2021
Reason Crystallization: customer complaints for crystallization in finished product.
Class I · High risk Terminated Feb 15, 2021
Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Class I · High risk Terminated Feb 15, 2021
Reason Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
Class I · High risk Ongoing Feb 2, 2021
Reason Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding…
Class I · High risk Ongoing Feb 2, 2021
Reason Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings…
Class I · High risk Ongoing Jan 27, 2021
Reason Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.
Class I · High risk Terminated Jan 27, 2021
Reason Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride…
Class I · High risk Terminated Jan 15, 2021
Reason Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50…
Class I · High risk Terminated Dec 23, 2020
Reason Presence of Particulate Matter - found in reserve sample vials at the firm.
Class I · High risk Ongoing Dec 17, 2020
Reason Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast
Class I · High risk Terminated Dec 7, 2020
Reason Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.
Class I · High risk Terminated Nov 25, 2020
Reason Failed Dissolution Specifications
Class I · High risk Terminated Nov 17, 2020
Reason Cross Contamination with other products: trace amounts of lidocaine
Class I · High risk Terminated Nov 17, 2020
Reason Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.
Class I · High risk Terminated Oct 28, 2020
Reason Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria…
Class I · High risk Completed Oct 27, 2020
Reason Microbial Contamination of Non-sterile Products: contamination with Burkholderia lata.
Class I · High risk Terminated Oct 5, 2020
Reason Non-Sterility
Class I · High risk Terminated Oct 5, 2020
Reason Non-Sterility